Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket

Published 13/09/2022, 11:15
Updated 13/09/2022, 12:10
© Reuters.  Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket

© Reuters. Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket

Gainers

  • Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average price of $2.03 - $2.07.
  • Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares rose 35.6% to $0.9906 in pre-market trading after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
  • Zovio Inc (NASDAQ: ZVO) rose 30.3% to $0.3074 in pre-market trading after declining over 5% on Monday.
  • iBio, Inc. (NYSE: IBIO) rose 18.1% to $0.32 in pre-market trading after declining over 4% on Monday.
  • American Rebel Holdings, Inc. (NASDAQ: AREB) rose 17.3% to $0.7798 in pre-market trading after surging around 15% on Monday.
  • SeaChange International, Inc. (NASDAQ: SEAC) shares rose 14.5% to $0.55 in pre-market trading after reporting strong Q2 sales.
  • The Very Good Food Company Inc. (NASDAQ: VGFC) rose 13.1% to $0.1899 in pre-market trading after declining around 6% on Monday. The Very Good Food Company, last week, announced a review of strategic alternatives.
  • Tyme Technologies, Inc. (NASDAQ: TYME) rose 12.7% to $0.29 in pre-market trading after gaining around 4% on Monday.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) rose 11.9% to $3.20 in pre-market trading after jumping around 28% on Monday.
  • Planet Labs PBC (NYSE: PL) rose 11.5% to $6.05 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance.
  • AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) rose 9.3% to $0.2747 in pre-market trading after dropping around 10% on Monday.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 7.8% to $43.32 in pre-market trading amid post-IPO volatility after the stock began trading in late August.
  • JE Cleantech Holdings Limited (NASDAQ: JCSE) rose 7.7% to $1.54 in pre-market trading after gaining over 5% on Monday.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) rose 7% to $16.21 in pre-market trading. S&P Dow Jones Indices said Catalyst Pharmaceuticals will replace Mantech International Corp. in S&P Smallcap 600 on September 15.
Don’t forget to check out our premarket coverage here .

Losers

  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) fell 25.3% to $12.46 in pre-market trading. NeuroBo Pharmaceuticals shares jumped 101% on Monday after the company announced a 1-for-30 reverse stock split.
  • Rent the Runway, Inc. (NASDAQ: RENT) shares fell 22.9% to $3.80 in pre-market trading after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse (SIX:CSGN) downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
  • Cardiff Oncology, Inc. (NASDAQ: CRDF) shares fell 19.3% to $2.59 in pre-market trading as the company announced plans for a randomized trial, durability of responses in ongoing Phase 1b/2 trial in metastatic colorectal cancer.
  • Tandy Leather Factory, Inc. (NASDAQ: TLF) fell 14.5% to $4.01 in pre-market trading.
  • Codiak BioSciences, Inc. (NASDAQ: CDAK) fell 14.4% to $1.43 in pre-market trading after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) fell 12.6% to $16.40 in pre-market trading. InMed Pharmaceuticals shares surged 70% on Monday after the company announced a $6 million private placement priced at $8.68 per share.
  • PolyPid Ltd. (NASDAQ: PYPD) fell 11.1% to $1.52 in pre-market trading after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
  • ShiftPixy, Inc. (NASDAQ: PIXY) shares fell 10.9% to $24.30 in pre-market trading. ShiftPixy shares dropped over 20% on Monday amid profit taking after the stock surged last week following the company's announcement it plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
  • Terns Pharmaceuticals, Inc. (NASDAQ: TERN) fell 10.4% to $5.11 in pre-market trading after gaining 8% on Monday.
  • Kiromic BioPharma, Inc. (NASDAQ: KRBP) fell 8.5% to $0.3475 in pre-market trading after gaining 7% on Monday.
  • Revance Therapeutics, Inc. (NASDAQ: RVNC) fell 7.4% to $26.00 in pre-market trading. Revance Therapeutics priced upsized 8 million share public offering of common stock at $25 per share.
  • Relay Therapeutics, Inc. (NASDAQ: RLAY) shares fell 4.5% to $27.51 in pre-market trading. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.